[144] Hims & Hers Health, Inc. SEC Filing

Rhea-AI Filing Summary

Hims & Hers Health, Inc. reported a proposed insider sale under Rule 144: 10,021 Class A shares are planned for sale through Fidelity Brokerage, with an aggregate market value of $506,060.50 and an approximate sale date of 09/17/2025 on the NYSE. The shares were acquired by restricted stock vesting from the issuer on 09/15/2025 as compensation.

The filing also discloses a recent disposition by the same person, Patrick H. Carroll, who sold 60,000 Class A shares on 08/06/2025 for gross proceeds of $3,214,880.58. The filer certifies they are not aware of any undisclosed material adverse information about the issuer.

Positive

• Transaction is a result of restricted stock vesting, indicating the shares were granted as compensation rather than purchased opportunistically
• Sale will be executed through a registered broker (Fidelity), suggesting standard market procedures and transparency

Negative

• Recent insider selling activity includes a prior disposal of 60,000 shares for $3,214,880.58, which may indicate notable insider liquidity
• Aggregate market value of the planned sale ($506,060.50) represents immediate insider monetization that investors may view as supply pressure

Insights

Securities Analyst

TL;DR: Insider plans to sell vested compensation shares (10,021 shares, ~$506k); prior large sale of 60,000 shares occurred in August.

The proposed sale reflects routine monetization of recently vested restricted stock rather than an open-market issuance. The size of the proposed sale (10,021 shares, $506k) is small relative to typical public float levels for a listed issuer, though materiality depends on total outstanding float not provided here. The disclosure of a prior sale of 60,000 shares for $3.21M is relevant for monitoring insider selling trends. No additional financial metrics or company operational details are included in this filing.

Corporate Governance Expert

TL;DR: Transaction appears to be compensation vesting followed by planned sale; disclosure aligns with Rule 144 requirements.

The filing documents that the securities were acquired via restricted stock vesting and the intended sale is executed through a brokerage firm, indicating standard compliance with resale rules. The signer’s representation that they have no undisclosed material information is customary and required. Absent other governance disclosures, this notice signals routine insider liquidity rather than governance concerns, though continued insider sales could warrant investor attention if they persist.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	10021	506060.50	217641958	09/17/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	09/15/2025	Restricted Stock Vesting	Issuer			10021	09/15/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Patrick H. Carroll 2269 Chesnut St #523 San Francisco CA 94123	Class A	08/06/2025	60000	3214880.58

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares is HIMS insider planning to sell?

The filer plans to sell 10,021 Class A shares through Fidelity Brokerage with an aggregate market value of $506,060.50.

When were the shares acquired that are being sold under Rule 144?

The shares were acquired on 09/15/2025 via restricted stock vesting and payment was recorded as compensation.

Has the seller made recent sales of HIMS stock?

Yes. Patrick H. Carroll sold 60,000 Class A shares on 08/06/2025 for gross proceeds of $3,214,880.58.

Through which exchange and broker will the sale occur?

The planned sale is listed as occurring on the NYSE through Fidelity Brokerage Services LLC.

Does the filer assert possession of undisclosed material information?

By signing the notice, the filer represents they do not know any undisclosed material adverse information regarding the issuer.